Product Information
TRIENTINE HCL 250 MG CAPSULE is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $2.3025 per EA under NDC 43598045901. Its NADAC has been published 62 times since Jun 18, 2025.
FDA first approved this application on Jul 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598045901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
TRIENTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211076FDA Approved
7/3/2019
TE Code
AB
On Market Since
7/3/2019
Pharmacological Classes
Price Statistics
The NADAC for TRIENTINE HCL 250 MG CAPSULE has been published 62 times since Jun 18, 2025, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3025 per EA |
|---|---|
| All-time high | $4.4843 (Jul 16, 2025) |
| All-time low | $2.3025 (Jun 17, 2026) |
| 52-week high | $4.3782 |
| 52-week low | $2.3025 |
| Median price | $4.3033 |
| Average price | $3.7280 |
| Largest weekly change | -21.6% (Mar 18, 2026) |
| Weeks tracked | 62 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIENTINE HCL 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TRIENTINE HCL 250 MG CAPSULE, manufactured by Dr. Reddy's Laboratories Inc., is $2.3025 per EA (NDC 43598045901), effective Aug 19, 2026.
How has the price of TRIENTINE HCL 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TRIENTINE HCL 250 MG CAPSULE has declined 48.7%. It has been tracked across 62 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for TRIENTINE HCL 250 MG CAPSULE?
Since Jun 18, 2025, the NADAC for TRIENTINE HCL 250 MG CAPSULE has ranged from a low of $2.3025 (Jun 17, 2026) to a high of $4.4843 (Jul 16, 2025), with a median of $4.3033 per EA.
Are there cheaper alternatives to TRIENTINE HCL 250 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRIENTINE HCL 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIENTINE HCL 250 MG CAPSULE?
TRIENTINE HCL 250 MG CAPSULE (NDC 43598045901) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.